Summary
The aim of this review is to determine the influence of coincidental cerebrovascular pathology on the symptomatology and course of Alzheimer’s disease (AD). The link between stroke and AD is probably higher than expected by chance for the following reasons: (i) both pathologies share genetic risk factors such as the ε4 allele of the apolipoprotein E gene; (ii) AD patients have changes in the brain vessels that may lead to either ischemic or hemorrhagic stroke or white matter changes or both; (iii) there is evidence of an increased risk of stroke in AD patients; (iv) there is evidence of a frequent association of AD and stroke at autopsy. Because of the summation of the various types of lesions, stroke lesions may lead to an increase progression of cognitive decline in AD patients. Recognition of a vascular component in a dementia syndrome is therefore useful for the management of AD patients. Whether an optimal management of risk factors for stroke may delay the clinical expression of dementia in patients with preclinical Alzheimer pathology should be evaluated.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Aharon-Peretz J, Cummings JL, Hill MA (1988) Vascular dementia and dementia of the Alzheimer type. Cognition, ventricular size and leuko-araiosis. Arch Neurol 45: 719–721
Albert MJ, Graffagnino C, McClenny C, DeLong D, Strittmatter W, Saunders AM, Roses AD (1995) ApoE genotype and survival from intracerebral haemorrhage. Lancet 346: 575
Alperovitch A, Mas JL, Doyon B, Myquel P (1986) Mortality from stroke in France 1968–1982. Neuroepidemiology 5: 80–87
Blots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE (1996) Common carotid intima media thickness predicts stroke in the Rotterdam study. J Neurol 243: 6
Bogucki A, Papierz W, Szymanska R, Staniaszczyk R (1988) Cerebral amyloid angiopathy with attenuation of the white matter on CT-scans: subcortical arteriosclerotic encephalopathy (Binswanger) in a normotensive patient. J Neurol 235: 435–437
Boone KB, Miller BL, Mehringer CM, Hill-Gutierrez E, Goldberg MA, Berman NG (1992) Neuropsychological correlates of white-matter lesions in healty elderly subject. A threshold effect. Arch Neurol 49: 549–554
Breteler MMB, Van Swieten JC, Bots ML, Grobbee DE, Claus JJ, van den Hout JHW, van Harskamp F, Tanghe HLJ, de Jong PRVM, van Gijn J, Hofman A (1994a) Cerebral white matter lesions, vascular risk factors, and cognitive function in a population-based study: The Rotterdam Study. Neurology 44: 1246–1252
Breteler MMB, Claus JJ, Grobbee DE, Hofman A (1994b) Cardiovascular disease and distribution of cognitive function in elderly people: the Rotterdam study. Br Med J 308: 1604–1608
Brun A, Englund E (1986) A white matter disorder in dementia of the Alzheimer type: a pathoanatomical study. Ann Neurol 19: 253–262
Cadelo M, Inzitari D, Pracucci G, Mascalchi M (1991) Predictors of leukoaraiosis in elderly neurological patients. Cerebrovasc Dis 1: 345–351
DeCarli C, Murphy DGM, Tranh M, Grady CL, Haxby JV, Gilette JA, Salerno JA, Gonzales-Aviles A, Horwitz B, Rapoport SI, Schapiro MB (1995) The effect of white matter hyperintensity volume on brain structure, cognitive performance, and cerebral metabolism of glucose in 51 healthy adults. Neurology 45: 2077–2084
Ellis RJ, Olichney JM, Thal LJ, Mirra SS, Morris JC, Beekly D, Heyman A (1996) Cerebral amyloid angiopathy in the brains of patients with Alzheimer’s disease: the CERAD experience, part XV. Neurology 46: 1592–1596
Erkinjuntti T, Hachinski VC (1993) Rethinking vascular dementia. Cerebrovasc Dis 3: 3–23
Erkinjuntti T, Ketonen L, Sulkava R, Sipponen J, Vuorialho M, Iivanainen M (1987) Do white matter changes on MRI and CT differentiate vascular dementia from Alzheimer’s disease? J Neurol Neurosurg Psychiatry 50: 37–42
Erkinjuntti T, Gao F, Lee DH, Eliasziw M, Merskey H, Hachinski VC (1994) Lack of difference in brain hyperintensities between patients with early Alzheimer’s disease and control subjects. Arch Neurol 51: 260–268
Ferrucci L, Guralnik JM, Salive ME, Pahor M, Corti MC, Baroni A, Havlik RJ (1996) Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc 44: 237–241
Fisher MC (1969) The arterial lesions underlying lacunes. Acta Neuropathol (Berl) 12:1–15
Frisoni G, Geroldi C, Blanquetti A, Trabucchi M, Govoni S, Franceschini G, Calabresi L (1994) Apolipoprotein e4 allele frequency in vascular dementia and Alzheimer’s disease (letter). Stroke 25: 1703
Fukuda H, Kobayaski S, Okada K, Tsunematsu T (1990) Frontal white matter lesions and dementia in lacunar infarction. Stroke 21: 1143–1149
Gerdes LU (1994) Apolipoprotein E genotypes and cardiovascular disease: a quantitative overview of 42 studies. Genet Epidemiol 11: 294
Haan J, Maat-Schieman MLC, Roos RAC (1994a) Clinical effects of cerebral amyloid angiopathy. Dementia 5: 210–213
Haan J, Maat-Schieman MLC, Van Duinen SG, Jensson O, Thorsteinsson L, Roos RAC (1994b) Co-localization of βA4 and cystatin C in cortical blood vessels in Dutch, but not in Icelandic hereditary cerebral hemorrhage with amyloidosis. Acta Neurol Scand 89: 367–371
Hachinski VC, Potter P, Merskey H (1987) Leuko-Araiosis. Arch Neurol 44: 21–23
Hénon H, Durieu I, Lucas C, Godefroy O, Pasquier F, Leys D (1996) Prevalence of preexisting dementia in consecutive stroke patients. Neurology 47: 852–853
Hénon H, Godefroy O, Lucas Ch, Pruvo JP, Leys D (1996) Risk factors for leuko-araiosis in stroke patients. Acta Neurol Scand 94: 137–144
Hijdra A, Verbeeten B Jr (1991) Leuko-araiosis and ventricular enlargement in patients with ischemic stroke. Stroke 22: 447–450
Hijdra A, Verbeeten B Jr, Verhulst JAPM (1990) Relation of Leukoaraiosis to lesion type in stroke patients. Stroke 21: 890–894
Hofman A, Ott A, Breteler MMB, Bots ML, Slooter AJC, Van Harskamp F, Van Duijn CN, Van Broeckhoven C, Grobbee DE (1997) Atherosclerosis, apolopoprotein E and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet 349: 151–154
Ince PG, McArthur FK, Bjertness E, Torvik A, Candy JM, Edwardson JA (1995) Neuropathological diagnoses in elderly patients in Oslo: Alzheimer’s disease, Lewy body disease, vascular lesions. Dementia 6: 162–168
Inzitari D, Diaz F, Fox A, Hachinski VC, Steingart A, Lau C, Donald A, Wade J, Mulic H, Merskey H (1987) Vascular risk factors and Leuko-Araiosis. Arch Neurol 44: 42–47
Inzitari D, Giordano GP, Ancona AL, Pracucci G, Mascalchi M, Amaducci L (1990) Leuko-araiosis, intracerebral hemorrhage and arterial hypertension. Stroke 21:1419–1423
Ishii N, Nishihara Y, Imamura T (1986) Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 36: 340–345
Jellinger K, Danielczyk W, Fischer P, Gabriel E (1990) Clinico-pathological analysis of dementia disorders in the elderly. J Neurol Sci 95: 239–258
Kinkel WR, Jacobs L, Polachini I, Bates V, Heffner RR Jr (1995) Subcortical arteriosclerotic encephalopathy (Binswanger’s disease). Computer tomographic nuclear magnetic resonance and clinical correlations. Arch Neurol 42: 951–959
Kokmen E, Whisnant JP, O’Fallon WN, Chu CP, Beard CM (1996) Dementia after ischemic stroke: a population-based study in Rochester, Minnesota (1960–1984). Neurology 46: 154–159
Leys D, Bogousslavsky J (1994) Mechanisms of vascular dementia. In: Leys D, Scheltens P (eds) Vascular dementia. ICG Publications, Dordrecht, pp 121–132
Leys D, Pruvo JP, Parent M, Vermersch P, Soetaert G, Steinling M, Delacourte A, Defossez A, Rapoport A, Clarisse J, Petit H (1991) Could Wallerian degeneration contribute to “Leuko-Araïosis” in subjects free of any vascular disorder? J Neurol Neurosurg Psychiatry 54: 46–50.
Leys D, Pruvo JP, Scheltens Ph, Rondepierre Ph, Godefroy O, Leclerc X, De Reuck J (1992) Leuko-araiosis. Relationship with the types of focal lesions occurring in acute cerebrovascular disorders. Cerebrovasc Disord 2: 169–176
Leys D, Hénon H, Pasquier F, Durieu I, Pruvo JP (1997) Medial temporal lobe atrophy in stroke patients: relationship with pre-stroke dementia. Neurology 48: A206
Liu CK, Miller BL, Cummings JL, Mehringer CM, Goldberg MA, Howng SL, Benson DF (1992) A quantitative MRI study of vascular dementia. Neurology 42: 138–143
Loeb C, Gandolfo C, Croce R, Conti M (1992) Dementia associated with lacunar infarction. Stroke 23: 1225–1229
Lucas C, Parent M, Delandsheer E, Delacourte A, Fournier Y, Defossez A, Leys D (1992) Hémorragies cér‘brales multiples et angiopathie amyloide de la substance blanche dans un cas de maladie d’Alzheimer. Rev Neurol (Paris) 148: 218–220
McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA work group under the auspices of department of health and human services task force on Alzheimer’s disease. Neurology 34: 939–944
Pasquier F, Leys D (1997) Why are stroke patients prone to develop dementia? J Neurol 244: 135–142
Pasquier F, Lebert F, Petit H (1994) Pseudo progressive dementia and “strategic” infarcts. In: Leys D, Scheltens P (eds) Vascular dementia. ICG Publications, Dordrecht, pp 47–54
Pasquier F, Lebert F, Petit H (1995) Dementia, apathy and thalamic infarcts. Neuropsychiat Neuropsychol Behav Neurol 8: 208–214
Rezek DL, Morris JC, Fulling KH, Gado MH (1987) Periventricular white matter lucencies in senile dementia of the Alzheimer type and in normal ageing. Neurology 37: 1365–1368
Rocca WA, Bonaiuto S, Lippi A, Luciani P, Turtù F, Cavarzeran F, Amaducci L (1990) Prevalence of clinically diagnosed Alzheimer’s disease and other dementing disorders: a door-to-door survey in Appignano, Macerata Province, Italy. Neurology 40: 626–631
Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, Amaducci L, Orgogozo JM, Brun A, Hofman A, Moody DM, O’Brien MD, Yamaguchi T, Grafman J, Drayer BP, Bennett DA, Fisher M, Ogata J, Kokmen E, Bermejo F, Wolf PA, Gorelick PB, Bick KL, Pajeau AK, Bell MA, DeCarli C, Culebras A, Korczyn AD, Bogousslavsky J, Hartmann A, Scheinberg P (1993) Vascular dementia: diagnostic criteria for research studies. Neurology 43: 250–260
Rubinsztein DC (1995) Apolipoprotein E: a review of its roles in lipoprotein metabolism, neuronal growth and repair and as a risk factor for Alzheimer’s disease. Psychol Med 25: 223–229
Saunders AM, Roses AD (1993) Apolipoprotein E allele frequency, ischemic cerebrovascular disease, and Alzheimer’s disease (letter). Stroke 24: 1416
Scheltens Ph, Barkhof F, Valk J, Algra PR, Gerritsen Van Der Hoop R, Nauta J, Wolters E Ch (1992) White matter lesions on magnetic resonance imaging in Alzheimer’s disease: evidence for heterogeneity. Brain 115: 735–743
Schmidt R (1992) Comparison of magnetic resonance imaging in Alzheimer’s disease, vascular dementia and normal aging. Eur Neurol 32: 164–169
Schmidt R, Fazekas F, Offenbacher H, Lytwyn H, Blematl B, Niederkorn K, Horner S, Payer F, Freidl W (1991) Magnetic resonance imaging white matter lesions and cognitive impairment in hypertensive individuals. Arch Neurol 48: 417–420
Schmidt R, Fazekas F, Kleinert G, Offenbacher H, Gindl K, Payer F, Friedl W, Niderkorn K, Lechner H (1992) Magnetic resonance imaging signal hyperintensities in the deep and subcortical white matter. A comparative study between stroke patients and normal volunteers. Arch Neurol 49: 825–827
Schmidt R, Fazekas F, Offenbacher H, Dusek T, Zach E, Reinhart B, Grieshofer P, Freidl W, Eber B, Schumacher M, Koch M, Lechner H (1993) Neuropsychologic correlates of MRI white matter hyperintensities: a study of 150 normal volunteers. Neurology 43: 2490–2494
Shimano H, Ishibashi S, Murase T (1989) Plasma apolipoproteins in patients with multi-infarct dementia. Atherosclerosis 79: 257–260
Skoog I, Lernfelt B, Landahl S, Palmertz B, Andreasson LA, Nilsson L, Persson G, Odén A, Svanborg A (1996) 15-year longitudinal study of blood pressure and dementia. Lancet 347: 1141–1145
Snowdon DA, Greiner LH, Mortimer JA, Riley KP, Greiner PA, Markesbery WR (1997) Brain infarction and the clinical expression of Alzheimer disease. The nun study. JAMA 277: 813–817
Steingart A, Hachinski VC, Lau C, Fox AJ, Fox H, Lee D, Inzitari D, Merskey H (1987) Cognitive and neurologic findings in demented patients with diffuse white matter lucencies on computed tomographic scan (Leuko-Araiosis). Arch Neurol 44: 36–39
Stephenson DT, Rash K, Clemens JA (1992) Amyloid precursor protein accumulates in regions of neurodegeneration following focal cerebral ischemia in the rat. Brain Res 593: 128–135
Tatemichi TK, Foulkes MA, Mohr JP, Hewitt JR, Hier DB, Price TR, Wolf PA (1990) Dementia in stroke survivors in the stroke data bank cohort. Prevalence, incidence, risk factors, and computed tomographic findings. Stroke 21: 858–866
Tatemichi TK, Desmond DW, Mayeux R Paik M, Stern Y, Sano M, Remien RH, Williams JBW, Mohr JP, Hauser WA, Figueroa M (1992) Dementia after stroke: baseline frequency, risks, and clinical features in a hospitalized cohort. Neurology 42: 1185–1193
Tatemichi TK, Paik M, Bagiella E, Desmond DW, Stern Y, Sano M, Hauser WA, Mayeux R (1994) Risk of dementia after stroke in a hospitalized cohort: results of a longitudinal study. Neurology 44: 1885–1891
Terayama, Meyer JS, Kawamura J, Weathers S, Mortel KF (1992) Patterns of cerebral hypoperfusion compared among demented and nondemented patients with stroke. Stroke 23: 686–692
van Swieten JC, Geyskes GG, Derix MMA, Peeck BM, Ramos LMP, van Latum JC, van Gijn J (1991) Hypertension in the elderly is associated with white matter lesions and cognitive decline. Ann Neurol 30: 825–830
Victoroff J, Mack WJ, Lyness SC, Chui HC (1995) Multicenter clinicopathological correlation in dementia. Am J Psychiatry 152: 1476–1484
Vinters HV (1987) Cerebral amyloid angiopathy. A critical review. Stroke 18: 311–324
Yamada M, Tsukagoshi H, Otomo E, Hayakawa M (1987) Cerebral amyloid angiopathy in the aged. J Neurol 234: 371–376
Ylikoski R, Ylikoski A, Erkinjuntti T, Sulkava R, Raininko R, Tilvis R (1993) White matter changes in healthy elderly persons correlate with attention and speed of mental processing. Arch Neurol 50: 818–824
Yoshimura M, Yamanouchi H, Kuzuhara S, Mori H, Sugiura S, Mizutani T, Shimada H, Tomonaga M, Toyokura Y (1992) Dementia in cerebral amyloid angiopathy: a clinicopathological study. J Neurol 239: 441–450
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1998 Springer-Verlag/Wien
About this paper
Cite this paper
Pasquier, F., Leys, D., Scheltens, P. (1998). The influence of coincidental vascular pathology on symptomatology and course of Alzheimer’s disease. In: Gertz, HJ., Arendt, T. (eds) Alzheimer’s Disease — From Basic Research to Clinical Applications. Journal of Neural Transmission. Supplementa, vol 54. Springer, Vienna. https://doi.org/10.1007/978-3-7091-7508-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-7091-7508-8_11
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-83112-0
Online ISBN: 978-3-7091-7508-8
eBook Packages: Springer Book Archive